Indometacin extended release - Beijing CoSci Med Tech
Latest Information Update: 29 Jul 2016
At a glance
- Originator Beijing CoSci Med-Tech
- Class Analgesics; Antirheumatics; Chlorobenzenes; Indoles; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Musculoskeletal disorders; Pain
Most Recent Events
- 29 Jul 2016 Chemical structure information added
- 25 Jul 2016 Investigation in Musculoskeletal disorders in China (PO)
- 25 Jul 2016 Investigation in Pain in China (PO)